A r t i c l e s Comprehensive understanding of biological systems requires the integration of molecular and structural information across multiple scales [1] [2] [3] [4] [5] [6] . Existing approaches can profile multiple biomolecules, but only within a few layers of cells [7] [8] [9] . Techniques for processing intact tissue [10] [11] [12] [13] [14] [15] [16] [17] enable organ-scale phenotyping, but can lead to information loss due to tissue damage and biomolecule degradation during processing, which may include digestion with proteases, delipidation, and exposure to high temperatures or dehydrating conditions. Such nonphysiological treatments can quench fluorescent proteins 13, 18 , degrade proteins 19 , hydrolyze transcripts 20 and damage tissue architecture.
Various approaches have been proposed to preserve biomolecules against stressors. For example, changing biomolecule−solvent interactions by tuning solvent polarity or incorporating additives can preserve biomolecules in extreme conditions, but this requires high concentrations of additives that may interfere with tissue processing and probe-target interactions 21 . Covalent modification with chemical fixatives or encapsulation in hydrogels can secure biomolecules [22] [23] [24] , but this is often accompanied by loss of biomolecule function and probe-binding affinity owing to structural and chemical damage 25, 26 . Preserving protein fluorescence is particularly challenging because small alterations in tertiary structure can quench signal 27 . So far, no single method simultaneously preserves the full fluorescence of proteins, the reactivity of proteins with specific probes, integrity of transcripts, and tissue architecture across organs.
Here we introduce SHIELD (stabilization to harsh conditions via intramolecular epoxide linkages to prevent degradation), a versatile method that simultaneously preserves key molecular informationprotein fluorescence, protein immunoreactivity and nucleic acids-in cleared intact tissues by using a polyfunctional, flexible epoxide. We attribute the cross-linker's protective mechanism to the formation of multiple flexible intramolecular bonds that enhance the stability of the protein's tertiary structure. When applied to tissue, SHIELD combined with SWITCH 14 enables uniform, organ-wide preservation of fluorescent protein activity, proteins, transcripts, and their probe-binding properties without loss of tissue architecture. SHIELD synergizes with several existing tissue processing technologies. For example, SHIELD combined with stochastic electrotransport 28 Understanding complex biological systems requires the system-wide characterization of both molecular and cellular features. Existing methods for spatial mapping of biomolecules in intact tissues suffer from information loss caused by degradation and tissue damage. We report a tissue transformation strategy named stabilization under harsh conditions via intramolecular epoxide linkages to prevent degradation (SHIELD), which uses a flexible polyepoxide to form controlled intra-and intermolecular crosslink with biomolecules. SHIELD preserves protein fluorescence and antigenicity, transcripts and tissue architecture under a wide range of harsh conditions. We applied SHIELD to interrogate system-level wiring, synaptic architecture, and molecular features of virally labeled neurons and their targets in mouse at single-cell resolution. We also demonstrated rapid three-dimensional phenotyping of core needle biopsies and human brain cells. SHIELD enables rapid, multiscale, integrated molecular phenotyping of both animal and clinical tissues.
A r t i c l e s RESULTS Polyepoxide protects GFP fluorescence from stressors We hypothesized that cross-linking surface-exposed protein residues with multiple flexible intramolecular bonds would provide structural reinforcement to enhance the stability of proteins. We screened polyepoxides because of their ability to form spontaneous cross-links with biomolecules under physiological conditions, backbone conformational flexibility and molecular diversity ( Fig. 1a and Supplementary  Table 1 ). Purified green fluorescent protein (GFP) was used as a model protein because loss of GFP fluorescence correlates directly with structural perturbations and loss of protein fluorescence affects many phenotyping technologies 29 (Fig. 1b) .
We first performed molecular dynamics simulations of GFP to determine the side chain-to-side chain distance of solvent-exposed nucleophiles (lysine, histidine, cysteine and tyrosine) and found that the cross-linkable pairs spanned distances with increasing frequency above 10 Å (Fig. 1c) . Cross-linkers thus should ideally possess multiple reactive groups that bridge side chain pairs to maximize the chance of forming intramolecular bonds. Among the lowest energy state conformers calculated for a library of epoxides ( Fig. 1a and Supplementary Table 1 ), we found that the polyepoxy compound polyglycerol-3-polyglycidyl ether (P3PE) had the highest count and broadest distribution of epoxide functional groups complementing the pairwise side chain distances of GFP ( Fig. 1d-h) .
We next reacted GFP with P3PE and other epoxide cross-linkers to investigate their protective properties. Mass spectrometry measured fewer than 14 P3PE molecules attached per GFP, compared to the 20 available reactive groups that reacted with monomeric glycidyl methyl ether, which is indicative of multipoint intraprotein crosslinking ( Supplementary Fig. 1 ). When we measured GFP fluorescence after exposure to denaturing conditions at 90 °C for 10 min or 70% methanol for 1 h, we found that fluorescence was best retained in both conditions by polyepoxy with three or more functional groups, with P3PE exhibiting among the best performance overall (Fig. 1i ). Under all conditions tested, P3PE outperformed commonly used protein stabilizers (for example, xylitol) 30 (Fig. 1i) .
To understand the protective mechanism of P3PE intramolecular cross-linking, we characterized the physicochemical properties of the P3PE-GFP conjugate using differential scanning calorimetry, circular dichroism and fluorescence spectroscopy. Differential scanning calorimetry showed that GFP cross-linked with dipropylene glycol diglycidyl ether or P3PE exhibited observable transitional enthalpy and an increased melting temperature (from 84 °C to 87 °C and 95 °C, respectively), whereas extensive aldehyde fixation (12 h at 37 °C) eliminated GFP's ability to undergo thermal denaturation 31 (Fig. 1j) . The presence of denaturation enthalpy indicates that the flexible polyglycerol backbone of the polyepoxy accommodates thermal fluctuations. This flexibility was further evident in acid denaturation-renaturation experiments 32 , in which P3PE partially preserved GFP's ability to refold but did not do so when GFP was reacted with glutaraldehyde (GA) and paraformaldehyde (PFA) (Fig. 1k) . The rigid nature of GA and PFA fixation compromises GFP structure, as seen from the disruption of the beta sheet circular dichroism spectra in favor of random coils 33 , which reduces fluorescence intensity (Fig. 1l,m) . In contrast, the P3PE-GFP conjugate retained both its native protein conformation and fluorescent signal (Fig. 1l,m) .
SHIELD protects fluorescent proteins without tissue autofluorescence increase
Consistent with our findings with purified GFP, tissue epoxidation can preserve fluorescent protein activity in tissue under harsh treatments. After heat exposure at 70 °C for 24 h, tissue reacted with P3PE retained GFP signal in Thy1::EGFP M-line brain slices, but PFA control or GA tissues did not ( Fig. 2a ). Of the polyepoxides tested, P3PE preserved signal best, and this protective effect extended to other fluorescent proteins ( Fig. 2b-d) . Moreover, P3PE-treated tissue retained GFP signal 50-400% more effectively than PFA-fixed tissue following exposure to detergents or organic solvents used in other tissue clearing methods ( Fig. 2e) . We termed the combination of tissue epoxidation with polyepoxide and subsequent delipidation SHIELD. We anticipate that SHIELD's ability to maximally preserve fluorescent protein signal can complement existing tissue-phenotyping methods requiring dehydration with alcohols, delipidation with organic solvents or detergents, or hydration with urea 18, 34 .
SHIELD tissue also exhibited inherently low tissue autofluorescence, in contrast to that treated with GA 35 , which increases background autofluorescence and complicates imaging of structures with low signals ( Fig. 2a,f) 14, 36 . For example, imaging of neurons expressing mOrange in neurites and GFP in synaptic clusters suffered from a poor signal-to-noise ratio (SNR) in GA-fixed tissue ( Fig. 2f,g) . By contrast, tissues epoxidated with P3PE under the same condition (37 °C, 6 h) exhibited low background autofluorescence across a wide spectral range ( Fig. 2h) , making it possible to image both individual neurites and their associated synaptic clusters with excellent SNR (Fig. 2f,g) .
SHIELD preserves organ-wide tissue physicochemical properties
We next determined whether SHIELD preserves endogenous proteins and their immunoreactivity. Of the 53 antibodies tested, all antibodies that were compatible with PFA-fixed control tissue were found to be compatible with SHIELD ( Supplementary Fig. 2 and Supplementary Table 2 ). Antibodies that poorly stained GA-treated tissue yielded better signal in SHIELD tissue, suggesting that epitopes affected by GA fixation were not perturbed by SHIELD (Fig. 2i,j and Supplementary Fig. 2 ). SHIELD's ability to cross-link tissue into a durable protein network allowed us to perform multiple rounds of immunostaining while retaining fluorescent protein signal (Fig. 2k,l and Supplementary Fig. 2) .
We further investigated whether SHIELD preserves transcripts in cleared organ-scale tissue. We confirmed the formation of covalent bonds between epoxides and nucleic acids using mass spectrometry ( Supplementary Fig. 1 ) 37 . To quantify the degree of transcript retention, we performed fluorescence in situ hybridization (FISH) on the poly(A) tail of mRNA using a 50-nt oligodeoxythymine ((dT) 50 ) labeled with Cy3 ( Fig. 2m,n) . The FISH signal in SHIELD tissue was higher than that in cleared PFA tissue and comparable to the signal obtained by 1-ethyl-3-3-dimethyl-aminopropyl carbodiimide (EDC) chemistry 12, 38 (Fig. 2m,n) , while maintaining higher fluorescent protein signal compared to EDC-CLARITY ( Supplementary Fig. 3 ). We were able to detect various mRNAs, including cell-type and neural activity markers, in SHIELD tissues (Fig. 2o,p and Supplementary Fig. 3 ).
SHIELD transforms entire organs into mechanically robust and transparent substrates while uniformly preserving fluorescent protein signals, protein antigenicity, transcripts and tissue architecture ( Figs. 2q and 3 and Supplementary Figs. 4 and 5) . We previously showed that a uniform and transparent tissue matrix can be obtained by controlling the kinetics of GA fixation using SWITCH (system-wide control of interaction time and kinetics of chemicals) 14 . In this method, we homogeneously dispersed GA in tissue by suppressing reactivity at pH 3 before initiating sample-wide cross-linking by shifting A r t i c l e s to a neutral pH. However, the low pH of the GA SWITCH-off buffer can denature fluorescent proteins and hydrolyze transcripts, and GA generates autofluorescent byproducts 32, 36 (Fig. 2f,g) . In contrast, we found that the reactivity of the polyepoxide can be controlled at more physiological conditions, where reactivity with primary amines was suppressed at 4 °C, pH 7.4, and increased by tenfold at 37 °C, pH 10 ( Supplementary Fig. 5 ). This SWITCH-mediated SHIELD reaction enabled preservation of transcripts in an intact organscale tissue cleared by stochastic electrotransport ( Fig. 2q and Supplementary Video 1).
SWITCH-mediated SHIELD also preserves organ-scale tissue architecture. Delipidation of mouse brains can collapse lipid-rich structures, which can deform connected regions and overall tissue structure ( Fig. 3a-d and Supplementary Fig. 4 ). In particular, PFAfixed tissues and polyacrylamide-tissue hybrids with a low degree of cross-linking or gel density can deteriorate under delabeling condition (70 °C for 2 h, 300 mM SDS) ( Fig. 3a,b and Supplementary  Fig. 4 ). Such widespread structural distortion can cause systematic errors in downstream image analysis and data interpretation. By contrast, SHIELD tissues exhibited no detectable distortion after delipidation and further destaining treatment ( Fig. 3a,b,d and Supplementary Fig. 4 ). 3D imaging of a SHIELD brain hemisphere showed excellent brain-wide preservation of GFP signal and tissue architecture (Supplementary Video 2). This minimal tissue distortion Figure 1 Protection of GFP activity with polyepoxide cross-linkers. (a) Representative lowest-energy conformers of epoxide molecules, drawn to the same scale as b. (b) GFP structure, with epoxide-reactive residues labeled in blue. The black arrow indicates a 7-Å distance between side chains. (c) Frequency count calculated for solvent-exposed GFP side chains (SC) as a function of their pairwise distances. (d-h) Frequency count of the average distance between epoxide groups, determined from the lowest-energy epoxide conformers. (i) Degree of GFP fluorescence preserved after reaction with cross-linkers (top) followed by exposure to 90 °C for 10 min (middle) or 70% methanol incubation for 1 h (bottom). N = 3 independent experiments. Mean ± s.e.m. (j) Differential scanning calorimetry plot of heat capacity as a function of the temperature of cross-linked GFP. (k) Plot of the fluorescence of cross-linked GFP recovered over time after renaturation from acid denaturation. (l) Fluorescence spectra of cross-linked GFP. (m) Circular dichroism spectra of cross-linked GFP. GME, glycidyl methyl ether; EGDGE, ethylene glycol diglycidyl ether; 1,4-BDE, 1,4-butanediol diglycidyl ether; DGDE, dipropylene glycol diglycidyl ether; TGE, glycerol triglycidyl ether; PEGE, pentaerythritol polyglycidyl ether; P3PE, polyglycerol 3-polyglycidyl ether; PFA, paraformaldehyde; GA, glutaraldehyde; TMAO, trimethylamine N-oxide.
A r t i c l e s enabled automated atlas alignment and region segmentation ( Fig. 3g) . SHIELD samples are rigid and can be handled repeatedly without structural damage ( Fig. 3e,f) . Compared to existing methods, the ability to lock both transcripts and proteins within transparent organs while maximally preserving endogenous fluorescence and tissue architecture is a signature advantage of SHIELD. (e) Photos of cleared 1-mm-thick mouse brain sagittal blocks on a rod. Interpolated centerlines of the tissues were marked with dots. (f) Quantification of tissue curvature; A.U., arbitrary units. N = 3 tissue samples. (g) Fully automated registration of autofluorescence images from a SHIELD mouse brain sample to autofluorescence images of the Allen Brain Atlas (© 2015 Allen Institute for Brain Science. Allen Brain Atlas API. Available from: http://brain-map.org/api/ index.html). Scale bars, 2 mm. Mean ± s.e.m. for all bar graphs. One-way ANOVA, Tukey's multiple comparison test, *P < 0.05, **P < 0.01, ***P < 0.001.
A r t i c l e s SHIELD enables integrated 3D mapping of the human brain The controllable reaction kinetics of SHIELD can be further applied to banked clinical samples to obtain a durable tissue gel capable of withstanding multiple rounds of staining and elution. To demonstrate the potential for generating integrated human brain maps using SHIELD, we processed a formalin-fixed 2-mm-thick coronal block of human brain taken at the posterior boundary of the occipital horn of the lateral ventricle (9 cm × 5.5 cm × 0.2 cm, aspect ratio 45:1) and passively cleared it at 80 °C for 10 d (Fig. 4a,b) . Although gray matters became fully transparent after a few days, we extended the incubation time to completely clear dense white matter. PFA-only and CLARITY tissues became severely damaged and mechanically unstable after full clearing. The high aspect ratio of such disintegrated tissue made it susceptible to additional physical damage during tissue handling. The tissue processed with SHIELD, however, was both transparent and structurally stable. Nuclear and vasculature labeling of the hybrid revealed macroscopic tissue architecture as well as individual cells ( Fig. 4c and Supplementary Video 3) .
SHIELD-processed human tissue was compatible with various cell-type and structural markers, and cyto-, chemo-and myeloarchitectural details could be visualized. In cortical tissue, we confirmed the presence of various interneurons, as well as glial cells ( Fig. 4d-i and Supplementary Video 4). In the cerebellum, calbindin staining provided rich morphological details, enabling cell-type classification based on both morphology and protein expression (for example, Purkinje cells) ( Fig. 4f) . We were also able to stain for neurofilament proteins and extracellular matrix protein ( Fig. 4d) . Myelin basic protein staining showed the myeloarchitecture of different brain regions ( Fig. 4f) . In the midbrain, neurofilament-L staining enabled delineation of individual nuclei and brain regions ( Fig. 4e ). Within these parcellated regions, we could probe for cell-type and morphological information by staining for tyrosine hydroxylase (Fig. 4e) . Taken together, these results show that SHIELD processing facilitates the simultaneous visualization of both structural and cellular features in human brain tissue, enabling integrated 3D human brain mapping at cellular resolution.
SHIELD allows new approaches in tissue phenotyping
We next tested whether SHIELD allows rapid phenotyping of freshly excised biopsies. Microscopic examination of a biopsy has been the gold standard for diagnosis of many diseases 39 . Conventional histology, however, requires laborious and slow processes to formalinfix, dehydrate, paraffin-embed, section and stain tissue samples. Relatively few of the slices produced by sectioning are imaged. The resulting sparse sampling and loss of volumetric information can limit diagnostic accuracy. Recent advances in tissue clearing techniques have enabled more holistic, volumetric imaging of intact biopsies [40] [41] [42] . These methods, however, rely on slow diffusion of chemicals and therefore become increasingly inefficient as the size of the biopsy increases.
SHIELD combined with stochastic electrotransport can preserve, clear and immunolabel intact needle biopsies within 4 h ( Fig. 5a-e ). The controllable SHIELD reaction kinetics enabled rapid conversion of a fresh biopsy sample into a clearable tissue-gel ( Fig. 5a,b) . We then used stochastic electrotransport to rapidly clear and uniformly label the intact sample with a vasculature marker and an antibody within 2 h (Fig. 5c,d and Supplementary Video 5). This pipeline is also applicable to PFA-fixed tissues. For example, we were able to visualize proliferating Ki-67-positive cells and vasculature in a PFAfixed mouse kidney harboring breast cancer metastasis ( Fig. 5e and Supplementary Video 6). Taken together, these results demonstrate that a SHIELD-based pipeline may enable rapid 3D phenotyping of intact biopsy samples.
Combining SHIELD with MAP (magnified analysis of the proteome) allows interrogation of fine structural and molecular features across large tissue volumes ( Fig. 5f-o) . Although MAP enables super-resolution imaging of millimeter-thick samples with diffraction-limited microscopes 13 , the harsh treatment required for isotropic expansion causes loss of fluorescent protein signal. Therefore, additional immunolabeling is necessary to image features tagged with fluorescent proteins. We discovered that an interpenetrating dense hydrogel can mechanically expand SHIELD-processed tissue isotropically by threefold without the need for harsh treatment (Fig. 5f-l) while effectively preserving signal from fluorescent proteins (Figs. 5g and 6). Distortion analysis of GFP-positive neurons before and after expansion showed less than 4% error across multiple length scales ( Fig. 5h,i) , which is comparable to results from previous expansion protocols 13, 19, 43 . Morphological details of dendritic spines were also well preserved after expansion ( Fig. 5j-l) .
SHIELD-MAP enabled super-resolution imaging of fine subcellular architecture labeled with fluorescent proteins in millimeterthick samples. Traditionally, imaging and volumetric reconstruction of synaptic input fields or dendritic arborization has been limited to specific classes of neurons confined to a small volume because it requires imaging with high numerical aperture (NA) objectives (NA 1.4) with a short working distance (200-300 µm) 44, 45 . SHIELD-MAP extends such studies to a wider range of neuronal types by enabling super-resolution imaging of signal from fluorescent proteins in tissue that is an order of magnitude thicker using medium-NA (1.0) objectives with a long working distance (8 mm) . We demonstrated imaging of dendritic spines expressing fluorescent protein in 5-mm-thick mouse brain tissue after expansion (Fig. 5m,n and Supplementary Video 7). Negligible loss of resolution and high fluorescent protein signal enabled the extraction of fine morphological features throughout the entire depth of the sample (Fig. 5n ) and the reconstruction of the dendritic arborization of a single neuron spanning a large tissue volume ( Fig. 5o and Supplementary Video 8).
Integrated cellular-resolution circuit mapping
We next applied SHIELD to comprehensively characterize a genetically defined neural circuit. The GPe is a major relay in the indirect pathway in the basal ganglia 46 and is thought to play a role in voluntary movements and movement disorders such as dystonia and Parkinson's disease 47 . About 40% of neurons in the GPe are PV + (ref. 48) , and their projections to several basal ganglia nuclei have been identified. However, it remains unclear how individual PV + neurons in the GPe (GPe-PV + neurons) project to multiple target areas at the single-cell level. SHIELD combined with viral labeling tools might enable integrated mapping of GPe-PV + long-range output, downstream target cells, and those cells' molecular properties at single-cell resolution.
To test this possibility, we targeted GPe-PV + neurons by injecting AAV-flex-mRuby2-Synaptophysin-EGFP virus into a PV-Cre transgenic mouse brain ( Fig. 6a) , which labeled neurites with mRuby2 and presynaptic boutons with EGFP 49 . We SHIELD-processed and stochastic electrotransport-cleared an intact mouse brain hemisphere, and imaged it using a light-sheet microscope ( Supplementary  Table 3 ) to map the global projection pattern of GPe-PV + neurons ( Fig. 6a-d and Supplementary Video 9). Negligible tissue distortion and fluorescent protein signal loss enabled automated atlas alignment, region segmentation and fluorescent protein signal detection ( Fig. 6c,d) .
We found GFP-labeled synaptic terminals in the GPe, subthalamic A r t i c l e s nucleus (STN), substantia nigra reticulata (SNr), globus pallidus interna (GPi), nucleus reticularis thalami (nRT), caudate putamen (CPu) and parafascicular nucleus (PF) ( Fig. 6b-d) .
To further investigate the PV-GPe circuit, we dissected a 1-mmthick tissue block that included the GPe, STN, nRT, GPi and SNr. We then performed FISH followed by delabeling and immunostaining to map Gad1 mRNA and calretinin protein (Fig. 6a,e and Supplementary Video 10). Finally, the tissue was expanded using SHIELD-MAP for super-resolution imaging ( Fig. 6a,e ).
All GPe-mRuby2 + neurons were Gad1 + and had synaptophysin-EGFP (Syp-EGFP + ) puncta on their somata, suggesting putative axosomatic connectivity among GPe-PV + neurons. To characterize the long-range output of a GPe-PV + neuron at single-cell resolution, we reconstructed the axonal arborization of an mRuby2 + neuron ( Fig. 6e,f) . The preservation of fluorescent protein signal and enhanced resolution obtained with SHIELD-MAP allowed reliable reconstruction of individual axons and their presynaptic boutons ( Fig. 6e-i and Supplementary Video 11). Negligible tissue damage and the isotropic expansion enabled integration of the molecular features acquired from the FISH and immunostaining rounds into the axogram (Fig. 6f,g) , which allowed molecular characterization of the traced neuron and its downstream targets ( Fig. 6f-m) .
The resulting multidimensional axogram suggested that the reconstructed neuron might be connected to 4 neurons in the GPe, Figure 4 SHIELD enables 3D imaging of various structures and cell types and their morphological details in human brain tissue. (a,b) A 2-mm-thick slab of human brain coronal hemisphere (9 cm × 5.5 cm × 2 mm) before (a) and after (b) SHIELD processing. Grid, 5 mm. (c) A SHIELD-processed slab (22 mm × 38 mm × 1.3 mm) was stained with lectin and nuclear dye, and the 800-µm-thick volume from the top surface was imaged with a custom-built, temporally focused line-scanning two-photon microscope. Scale bars: 2 mm (blue, left) or 100 µm (white). See Supplementary Video 3.
(d-f) Immunostained cortex (d), midbrain (e) and cerebellum (f) from 100-µm-thick SHIELD-processed human brain tissues, showing various cell types and structures. In e, neurofilament-L (NF-L) staining assists delineation of midbrain areas. NPY, neuropeptide Y; CR, calretinin; Iba1, ionized calciumbinding adaptor molecule 1; MMP-13, matrix metallopeptidase 13; GFAP, glial fibrillary acidic protein; CB, calbindin; MBP, myelin basic protein; TH, tyrosine hydroxylase; SC, superior colliculus; PAG, periaqueductal gray; SN, substantia nigra. Scale bars: 2 mm (blue, top row in e) or 50 µm (white). A r t i c l e s 2 neurons in the nRT and 13 neurons in the SNr through putative axosomatic synapses ( Fig. 6f) . Most of the downstream targets were Gad1 + . In the SNr, all downstream targets of this neuron were CR − despite the finding that 22% of SNr neurons with EGFP + axosomatic boutons were CR + (Fig. 6k) . Eighty-five percent of Syp-EGFP + SNr neurons were Gad1 + (Fig. 6j) .
We found that the reconstructed neuron innervated the STN through three different axon collaterals originating from two axon hillocks ( Fig. 6e,f) . Collaterals to the nRT or SNr were from a single axon hillock ( Fig. 6e,f) . Statistical analysis of presynaptic ultrastructure revealed the number of bifurcations near the target neuronal soma to be positively correlated with the total number of axosomatic boutons ( Fig. 6l) . A subset of Gad1 + SNr neurons received putative axosomatic inputs from multiple collaterals bifurcating far from their target soma (92.2 ± 16.1 µm linear distance before expansion, N = 3 cases) ( Fig. 6f-i) . These data show that SHIELD together with MAP enables integrated multiscale circuit mapping with unprecedented resolution and accuracy. This approach may provide an anatomical framework for understanding neural circuit mechanisms.
DISCUSSION
In this study, we identified a polyepoxide for advanced tissue processing that possesses several key properties, including polyfunctional reactive groups with a flexible backbone for the formation of intra-and A r t i c l e s intermolecular bonds, reactivity to various classes of biomolecules, and tightly controllable reaction kinetics under mild conditions. By promoting multipoint intramolecular fluorescent protein cross-links, SHIELD safeguards fluorescent protein signal against harsh conditions commonly used in many tissue phenotyping methods. Controlled tissue epoxidation effectively cross-links both proteins and nucleic acids while preserving their probe-binding affinities to various commercially available antibodies and FISH reagents. Epoxidation also protects tissue architecture during delipidation and destaining.
SHIELD combined with SWITCH can effectively preserve endogenous molecules, protein fluorescence and tissue architecture uniformly in both intact mouse hemispheres and long-banked clinical samples. SWITCH ensures uniform dispersion of polyepoxide throughout a large-scale sample before the synchronized initiation of the epoxidation reaction, enabling the preservation of tissue-wide physicochemical properties. Key parameters (for example, incubation time) of SWITCH-mediated tissue epoxidation will, however, need to be optimized for different types of samples.
Recently, tissue-clearing techniques have been applied to biopsy samples to demonstrate the potential of 3D pathology approaches to improve the diagnosis and treatment of cancer [40] [41] [42] . These benefits, however, were moderated by a lengthy processing time or potential damage to tissue architecture. By contrast, the SHIELD and stochastic electrotransport processing pipeline enabled 3D molecular phenotyping of intact needle biopsies with very high speed (4 h for a 1-mm-diameter biopsy). This pipeline could be used to quickly determine a tumor's subtype and heterogeneity in clinical labs when timely treatment is required.
Recent advances in viral labeling, tissue processing and imaging technologies have enabled mapping of long-range wiring in mouse brains [50] [51] [52] . For instance, Ye et al. 50 demonstrated brain-wide mapping of axonal bundle projections using CLARITY. Economo et al. 51 developed a platform for brain-wide imaging and reconstruction of long-range axonal arbors at single-fiber resolution using partial tissue clearing and a high-speed two-photon microscope integrated with a tissue vibratome. However, molecular phenotyping of the very same cells with known axonal projection pattern and identifying their downstream target cells, which is crucial in understanding cell function, remains challenging.
When combined with genetic and viral tools, SHIELD may serve as a powerful platform for integrated multiscale interrogation of neural circuits. The high level of fluorescent protein preservation in SHIELD and SHIELD-MAP enabled repeated imaging of fluorescent protein-labeled neuronal structures across multiple scales, from whole brain to submicron architectures (for example, synaptic puncta). We demonstrated that global projection patterns can be mapped using SHIELD followed by SHIELD-MAP for A r t i c l e s super-resolution imaging of regions of interest in the same brain to reconstruct individual axonal projections and synaptic structures. Thanks to high fluorescent protein signal and low background, we were able to use low laser power to image multiple fluorescent proteins repeatedly with minimal photobleaching. Even though SHIELD-MAP decreases fluorescent protein density by 27-fold owing to threefold linear expansion, we were still able to clearly and rapidly image both fluorescent protein-labeled axonal fibers and presynaptic puncta. SHIELD and SHIELD-MAP enable extraction and integration of brain-wide wiring, single-cell-resolution axograms, and the molecular features of downstream neurons from the same brain. To demonstrate, we reconstructed the axogram of a GPe-PV + neuron, including its axon arborization patterns and molecular details of its downstream targets, and their putative axosomatic connectivity with presynaptic bouton numbers. We claim only putative axosomatic connectivity because we used presynaptic boutons adjacent to somata as the sole indicator of neuron-to-neuron connection. Additional multiplexing with postsynaptic proteins (for example, PSD95) and dendritic proteins (for example, MAP2) may allow more precise mapping of synaptic connections using SHIELD.
We anticipate that existing tissue phenotyping methods requiring unphysiological treatment will benefit from SHIELD, as it protects biological tissue against a wide range of stressors. The integration of SHIELD with other protocols may, however, require systematic optimization because tissue epoxidation changes the degree of structural and molecular preservation, which subsequently affects downstream processing. For example, SHIELD treatment increases the amount of biomolecule and structural feature preservation, which can decrease tissue permeability and slow molecular transport. Therefore, subsequent steps that require molecular transport will need to be optimized. Penetration depth of molecular probes in SHIELD tissue is dependent on tissue type, specimen size, and copy number and distribution patterns of target molecules. SHIELD enables high-SNR imaging of a wide range of biomolecules thanks to a minimal loss of endogenous molecules and their probe binding affinities. To avoid depletion of molecular probes by high-copy-number targets, we recommend using SWITCH to control probe-target binding kinetics. Stochastic electrotransport further enhances speed and uniformity of labeling in various types of tissues and organs 28 . The processing time and the required probe amount would need to be empirically determined for each target and sample type, as in all other tissue phenotyping methods.
SHIELD in combination with DNA and RNA FISH approaches can facilitate spatial genomics 53, 54 and the integration of single-cell sequencing analysis into a 3D cell map of model systems and clinical samples 7 . SHIELD can also be used for volumetric mapping of gene expression profiles in whole-mount intact tissues at single-cell resolution using multiplexed FISH techniques 53, 54 .
Polyepoxide and other multifunctional cross-linkers have been widely used in various industries as coating resins, adhesives and embedding media for electron microscopy 55 . A large library of multifunctional cross-linkers is available, and new chemicals with different functionalities are currently being developed. We envisage rationally guided screening or design of new multifunctional cross-linkers further enhancing the utility of the SHIELD approach.
The versatility of SHIELD combines many advantages of existing methods into a simple, scalable and broadly applicable protocol. SHIELD synergizes with a wide range of technologies and will enable new integrated approaches for studying complex biological systems.
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ONLINE METHODS
Protocols. Detailed protocols are available online (http://www.chunglabresources.com).
Molecular dynamics simulations.
One hundred epoxide conformers in the fully ring-opened amine-reacted state were generated using the distance geometry method implemented in RDKit. After discarding conformers within 0.5-Å heavy atom r.m.s. deviation, the remaining structures were minimized with the MMFF94 force field 56, 57 . Conformers were sorted by their MMFF energy and filtered again for uniqueness using a 1.0-Å heavy atom r.m.s. deviation cutoff on the postminimization geometries. Distances between the side-chainmimicking nitrogen atoms were measured for the final minimized conformers.
A 227-residue, 3,567-atom EGFP (PDB ID: 4EUL) model was used for this study, where the chromophore was replaced with an alanine residue to simplify force field assignments. EGFP was protonated using the H++ webserver assuming a pH of 7.0, which yielded a net charge of −7. All simulations were carried out with the AMBER16 suite and with the AMBER tleap program for further protein preparation. A rectangular prism of water was added by adding at least 20 Å water buffer from the edge of the protein before NPT equilibration with periodic boundary conditions. A neutral simulation cell was obtained by adding Na + charges to this water cell, producing an initial simulation box roughly 89 × 95 × 100 Å in size and containing 73,846 atoms. The AMBER ff14SB force field was used for the protein in MM simulations along with a TIP3P water force field and standard AMBER Na + force field parameters.
Before production molecular dynamics, equilibration was carried out as follows: (i) 1,000 constrained-protein (i.e., only solvent and ions are minimized while the protein is held fixed) and 2,000 free-protein minimization steps (i.e., everything in the system is minimized), (ii) 20 ps quick NVT heating to 50 K with a 0.5-fs time step, (iii) 20 ps quick NVT heating from 50 K to 300 K with a 0.5-fs time step, and (iv) 1.05 ns NPT equilibration (P = 1 bar, T = 300 K) with a 2-fs time step. Following this equilibration, 100 ns of NpT production dynamics was carried out. A Langevin thermostat was employed with a collision frequency of 5.0 ps −1 in all constant temperature equilibration or production, and a Berendsen barostat with a pressure relaxation time of 2.0 ps was employed for all constant pressure equilibration or production. A random seed was used to avoid synchronization artifacts in the case of Langevin dynamics constant temperature simulation. For all cases, at minimum the backbone (i.e., amide C or N and Cα atoms) of the protein were held fixed with a 500 kcal mol −1 Å −2 restraint to sample only configurational side chain dynamics of EGFP with the backbone held fixed to its orientation in the 1.35-Å resolution crystal structure 58 . In all cases, the SHAKE algorithm 59 (i.e., fixed X-H bonds) was employed to enable longer, 2-fs time steps, but shorter time steps were used during equilibration to avoid bubble formation during box size adjustment. For the long-range electrostatics, the particle mesh Ewald method was used with a 10-Å electrostatic cutoff.
Surface exposed residues were defined based on consensus of two metrics over the course of the entire 100-ns trajectory, as judged by analysis on 50,000 evenly spaced frames. The following metrics were employed. (1) A residue was considered buried if its side chain atom (lysine N, cysteine S, tyrosine O, histidine either N) had less than 2.5 Å 2 exposure to solvent. The surface was calculated using a 1.4-Å-radius probe with an in-house Python script that used the PyMOL dot_solvent built-in command. (2) The full residue's contribution to the total protein solvent-exposed surface area (SASA) was computed using the cpptraj utility in the AMBER suite over the trajectory, and the average, maximum and minimum contribution to SASA was retained. A buried residue based on the AMBER estimation will have a negative SASA. Residues that were deemed exposed in <10% of frames based on criterion 1 and had negative average or low maximum contributions to SASA were deemed buried for this analysis. This assignment of buried versus exposed was also verified by visual inspection. From 39 candidate epoxide-functionalization sites (i.e., lysine, cysteine, histidine and serine residues), 8 residues were judged to be buried (C48, C68, Y72, K83, Y90, Y104, H179 and H197) whereas the remaining 31 residues were deemed surface exposed (K3, H25, K26, Y39, K41, K45, K52, H75, K77, H79, K99, K105, K111, K124, K129, H137, K138, Y141, Y143, H146, Y149, K154, K156, K160, K164, H167, Y180, Y198, K207, K212 and H215). The trajectory from production dynamics was analyzed by computing all possible side chain-side chain distances on the surface-exposed, candidate epoxide functionalization sites of EGFP using a combination of the cpptraj utility in AMBER and our own in-house Python code. Analysis of minimum, maximum and average pairwise distances between the functional groups of only surface-exposed residues was carried out with in-house Python code and used to generate the histogram featured in the main text.
Recombinant GFP expression and purification. EGFP plasmid (Champion pET SUMO Expression System, Thermo Fisher) was transformed into BL21 E. coli competent cells and amplified in 1 L Terrific Broth (overnight, 37 °C) to an OD 600 of 0.5-0.6. EGFP expression was induced by adding IPTG (1 mM final concentration; overnight, 37 °C). The culture was pelleted and resuspended in lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM imidazole) and lysed by sonication followed by centrifugation at 31,400g (20 min, 4 °C). EGFP was purified with an Ni-NTA column with a 50-mL wash (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 25 mM imidazole) and eluted (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 500 mM imidazole). EGFP was further purified by size-exclusion gel chromatography using FPLC twice, first to remove imidazole and then to remove cleaved SUMO protein.
Preparation of epoxide solution.
Glycidyl methyl ether (GME) was purchased from Sigma-Aldrich (cat no. 454680). The polyepoxide resins of ethylene glycol diglycidyl ether (EGDGE, product name EGDGE), 1,4-butanediol diglycidyl ether (1,4-BDE, product name GE21), dipropylene glycol diglycidyl ether (DGDE, product name GE23), polyglycerol 3-polyglycidyl ether (P3PE, product name GE38) and pentaerythritol polyglycidyl ether (PEGE, product name GE40) were provided by CVC Thermoset Specialties of Emerald Performance Materials. The resin of glycerol triglycidyl ether (TGE, product name EX-313) was provided by Nagase America Corporation. The resins were weighed and dissolved in an aqueous solution and then thoroughly vortexed for 1 min. The resulting suspension was centrifuged for 5 min at 7,200g. and the supernatant was collected. This procedure was repeated until the supernatant became fully transparent. Most of the GE38 resin is water insoluble. From BSA amine reaction assay, we found that the amine reactivity of supernatant of 1% (w/v) GE38 at 37 °C in pH 10, 0.1 M sodium carbonate buffer is comparable to that of 0.475% (w/v) PFA in pH 7.4, 0.1 M sodium phosphate buffer with 10 mM NaCl at room temperature (RT). We prepared the following solutions using the supernatant of 10 or 20% (w/v) GE38 resin: SHIELD perfusion solution: ice-cold PBS containing 4% (w/v) PFA and GE38 supernatant.
SHIELD-OFF solution: ice-cold PBS containing GE38 supernatant SHIELD-ON solution: 0.1 M sodium carbonate buffer at pH 10, prewarmed to 37 °C SHIELD whole organ processing protocol. Fixation. Mice were transcardially perfused with ice-cold PBS and then with the SHIELD perfusion solution. Dissected brains or organs were incubated in the same perfusion solution at 4 °C for 48 h. Tissues were then transferred to the SHIELD-OFF solution and incubated at 4 °C for 24 h. In the case of brain hemisphere clearing, an intact whole brain was split into hemispheres before being incubated in the SHIELD-OFF solution. Following the SHIELD-OFF step, the organs were placed in the SHIELD-ON solution and incubated at 37 °C for 24 h. Alternatively, if the tissues had been previously fixed with PFA, samples were washed in PBS with 0.02% sodium azide at RT for at least 24 h, and then incubated in the SHIELD-OFF solution for 3 d (in case of mouse brain hemispheres) at 4 °C. The final SHIELD-ON step was the same as the procedure for perfused tissue described above.
Delipidation. SHIELD-fixed organs were cleared passively for a couple of weeks (10-14 d at 45 °C for a mouse brain hemisphere) in SDS-based clearing buffer (300 mM SDS, 10 mM sodium borate, 100 mM sodium sulfite, pH 9.0) or rapidly cleared (<3 d for a mouse brain hemisphere) using stochastic electrotransport (SmartClear Pro, LifeCanvas Technologies).
Optical clearing. Delipidated tissues were incubated in Protos-based immersion media (125 g iohexol, 3 g diatrizoic acid, 5 g N-methyl-d-glucamine dissolved in 100 mL deionized (DI) water with the refractive index adjusted to 1.458 by adding DI water, or 50 g diatrizoic acid, 40 g N-methyl-d-glucamine, 55 g iodixanol in 100 mL DI water with the refractive index adjusted to 1.458 by adding DI water) until the tissue became transparent without any visible haze at the tissue-medium interface.
GFP fluorescence retention screen. An aliquot of GFP at a concentration of 0.5 mg/mL was reacted in either the supernatant of 1% (v/v) epoxide suspended in 0.1 M sodium carbonate buffer at pH 10 or aldehyde fixative in PBS for 12 h at 37 °C. Excess cross-linker was removed by centrifugal filtration (10 kDa MWCO, Amicon), and the GFP was reconstituted in 0.1 M HEPES buffer at pH 7.5. Cross-linked GFP (0.1 mg/mL) or GFP in additive solution (0.1 mg/mL in 0.1 M of xylitol, sorbitol, trimethylamine N-oxide or trehalose) was exposed to 90 °C for 10 min or incubated in 70% (v/v) methanol for 1 h. Fluorescence was quantified with a UV-visible spectrometer (EnSpire Multimode Plate Reader 2300, PerkinElmer).
Physiochemical characterization of GFP. An aliquot of the cross-linked GFP solution was obtained using the same protocol as for the fluorescence retention screen. Differential scanning calorimetry (MicroCal VP-DSC, Malvern Instruments) was performed on the cross-linked GFP solution at a heating rate of 1.5 °C/min (2 mg/mL, 0.1 M HEPES, pH 7.5). Circular dichroism spectra (J-1500 CD Spectrometer, JASCO) were collected from the cross-linked GFP solution (0.1 mg/mL in 10 mM sodium carbonate buffer at pH 8). GFP refolding experiments were performed according to previously established protocols. Briefly, 50 µL of GFP (1 mg/mL, 50 mM HEPES, pH 7.5) was combined with 50 µL dithiothreitol solution (2 mM dithiothreitol, 50 mM HEPES, pH 7.5) and incubated for 5 min. Then 100 µL of 0.1 M HCl was added and the mixture was incubated for an additional 5 min. Refolding was initiated by diluting the GFP mixture in TNG (0.1 M Tris, pH 7.5, 150 mM NaCl, 10% [w/v] glycerol) at a ratio of 1:10. Fluorescence recovery was measured using a UV-visible spectrometer (EnSpire Multimode Plate Reader 2300, PerkinElmer).
Amine reactivity quantification. o-Phthaldialdehyde (OPA) reagent (Fluoraldehyde, Thermo Fisher) was used to quantify the degree of epoxidation of amine residues on GFP and bovine serum albumin (BSA) proteins. BSA (1 mg/mL) was reacted with the supernatants of 1% (v/v) fixative for 12 h at 37 °C (0.1 M carbonate buffer at pH 10 for epoxides, PBS at pH 7.4 for aldehydes). After removing excess reactants by filter centrifugation (3× PBS with the Amicon Ultra 30K NMWL, Millipore), 10 µL of reacted BSA (1 mg/mL reacted BSA in PBS) was incubated with 200 µL OPA and measured within 5 min (Ex350, Em450). To determine the SWITCH on/off condition of P3PE, 100 mg/mL BSA was incubated with the supernatant of 10% (w/v) P3PE for 1 d in either 0.1 M sodium phosphate dibasic and 10 mM NaCl solution buffered at pH 7.4 at 4 °C or 0.1 M sodium carbonate solution buffered at pH 10 at either 4 °C or 37 °C. Aliquots were removed and diluted by 20fold in the same pH buffers to be measured within the linear response of the OPA reagent, and the degree of epoxidation was quantified with OPA without further purification. Measured values were normalized to the values obtained from BSA stock solutions at various concentrations, immediately after the addition of cross-linkers. 15 and (dC) 15 single-strand DNA oligonucleotides synthesized by IDT were used for testing nucleic acid reactivity to epoxides. Due to the difficulty in synthesis of polydeoxyguanine, we excluded the (dG) 15 oligonucleotide. We also excluded polydeoxythymine due to its weak nucleophilicity, yielding minimal cross-linking. Oligonucleotides at 250 µM were reacted with 1% (w/v) GME or the supernatant of 5% (w/v) P3PE in 0.1 M sodium carbonate buffer (pH 10) for 15 h (GME) or 2 d (P3PE) at 37 °C. The resulting reaction mixtures were subject to the standard ethanol precipitation to remove salts and unreacted epoxides and their molecular weight changes were determined by the MALDI mass spectrometry.
Nucleic acid reactivity. (dA)
Mass spectrometry. Cross-linked BSA (1 mg/mL) was concentrated 40-fold (Amicon, 30 kDa MWCO, Millipore). An aliquot of 1 µL of cross-linked BSA was mixed with 4 µL of 10 mg/mL sinapinic acid matrix solution in 50% acetonitrile, 0.1% trifluoroacetic acid and spotted on a MALDI sample plate. An aliquot of 1 µL of cross-linked oligonucleotide after ethanol precipitation and tenfold dilution with Millipore water was mixed with 1 µL of the 9:1 mixture of 50 mg/mL 3-hydroxypicolinic acid in 50% acetonitrile and 50 mg/mL diammonium hydrogen citrate in Millipore water as a matrix. MALDI mass spectra were acquired by a Bruker MicroFlex MALDI-TOF mass spectrometer.
Mice. Young adult (2-4 months; median age 3 months) C57BL/6 mice were housed in a 12 h light/dark cycle with unrestricted access to food and water. All experimental protocols were approved by the MIT Institutional Animal Care and Use Committee and the Division of Comparative Medicine and were in accordance with guidelines from the National Institute of Health. All experiments using mice were conducted in strict adherence to the ethical regulations of MIT Institutional Animal Care and Use Committee and the Division of Comparative Medicine. The following transgenic lines were used for this study: Thy1::GFP M-line, Thy1::YFP H-line, ChAT BAC -eGFP (Jackson stock no. 007902), PV-Cre loxP-tdTomato (Jackson stock no. 017320 and 007914) and Fos-CreER T2 DIO-tdTomato (Jackson stock no. 021882, 007914). For the footshock experiment, mice were habituated in the fear-conditioning box for 10 min, followed by two sequential 5 s of 0.6-mA electric shocks at a 30-min interval. Five minutes after the second electric shock, mice were perfused.
Fluorescent protein tissue epoxide screen. The 100-µm coronal slices were obtained from the 4% (w/v) PFA-perfused Thy1::GFP M-line mouse. The slices were incubated in 1% fixative solution (1% w/v GA in PBS; the supernatant of 1% w/v epoxide in 0.1 M sodium bicarbonate buffer pH 9.5) for 6 h at 37 °C and washed with an excess of PBS containing 0.1% (w/v) Triton-X 100 (PBST). Additional 100-µm slices were obtained from CLARITY-embedded brains 50 . Processed slices were heated to 70 °C in PBS for 24 h. The entire coronal slice was imaged before (after PFA fixation only) and after thermal or chemical treatment (after tissue processing). Fluorescence retention was calculated with ImageJ by normalizing the mean intensity signal from the same five regions before and after treatment following background subtraction (N = 3 tissues samples). Tissue slices with neurons expressing different fluorescent proteins were similarly processed and analyzed.
Fluorescence retention after exposure to chemical conditions was quantified with Thy1::GFP M-line 100-µm coronal slices. Slices were processed with 80% (v/v) methanol in DI water (RT, 4 d), 100% THF (RT, 12 h), uDISCO (50%, 80%, 95%, 100% (v/v) tert-butanol dehydration (37 °C, 15 min each step) and BABB-D4 (benzyl alcohol, benzyl benzoate and diphenyl ether at a ratio of 4:8:1) for 1 h), CUBIC-L (5% (w/v) Triton X-100, 5% (w/v) N-butyldiethanolamine; 37 °C, 5 d) and SDS clearing buffer (200 mM SDS, 100 mM sodium sulfite and 10 mM sodium borate pH 9.5; 37 °C or 56 °C, 12 h). Note that thereafter when we refer the SDS clearing buffer, it contains either 200 or 300 mM SDS, 100 mM sodium sulfite and 10 mM sodium borate at pH 9.0 or 9.5 (indicated in each section).
Preparation of PFA, GA, PACT and iDISCO+ tissues.
For PFA tissue preparation, mice were intracardially perfused with ice-cold PBS, with ice-cold 4% (w/v) PFA in PBS (5 mL/min), and then dissected tissues were postfixed in PBS with 4% (w/v) PFA at 4 °C for 48 h. Fixed tissues were washed with PBS with 0.02% sodium azide at room temperature overnight.
To prepare GA-processed mouse brains, ice-cold 4% (w/v) PFA, 1% glutaraldehyde (16310, Electron Microscopy Sciences) in PBS (5 mL/min) was prepared (glutaraldehyde was added after the PFA-containing PBS solution cooled to 4 °C) and then used for perfusing the mouse after ice-cold PBS perfusion. After 2 d of postfixation in the perfusion solution containing fixatives, brains were split into hemispheres and then washed with PBS containing 0.1% Triton-X100 and 0.02% sodium azide at room temperature overnight. Tissues were inactivated in PBS with 1% (w/v) acetamide and 1% (w/v) glycine at 37 °C overnight and then washed with PBS with 0.02% sodium azide at room temperature overnight.
PACT tissue preparation was done based on the previous publication 60 . Briefly, PFA brains postfixed at 4 °C for 24 h were split into hemispheres and then moved to ice-cold hydrogel monomer solution (4% acrylamide and 0.25% azo-initiator VA-044 in PBS), then incubated at 4 °C for 24 h. Brain in 10 mL of the hydrogel monomer solution was gelated under nitrogen gas purging (10 p.s.i.) at 37 °C for 2 h. Excess hydrogels were washed with PBS with 0.02% sodium azide at room temperature overnight.
CLARITY tissues for immunoreactivity ( Fig. 2i,j) , autofluorescence ( Fig. 2g) and tissue rigidity (Fig. 3g,h) comparisons were prepared based on Kim et al. 28 with some modifications. Hydrogel monomer solution was made with 4% (w/v) acrylamide (A3553, Sigma), 0.25% (w/v) VA-044 (Wako Chemicals), 4% (w/v) PFA (15714-S, Electron Microscopy Sciences) in PBS (70011-044; Invitrogen). After perfusion with ice-cold PBS, mice were perfused with 20 mL of the hydrogel monomer solution, followed by incubation in the monomer solution at 4 °C for 72 h. The brains were split into hemispheres and were moved to 10 mL of fresh hydrogel monomer solution. Samples were gelated at 37 °C for 2 h with nitrogen gas purging (10 p.s.i.). After retrieval from the polymerized solution, gel pieces on the hemisphere surface were gently removed and the hemispheres were washed with PBS with 0.02% sodium azide at room temperature overnight. For EDC-CLARITY experiments, CLARITY-processed brains were sliced into 100-µm sections and then postfixed in EDC-based solution (0.1 M 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, 0.1 M 5-ethylthio-1H-tetrazole, 0.1 M methylimidizole pH 8.5) overnight at 37 °C (ref. 12 ) and used for oligo-dT staining. For tissue integrity comparisons ( Fig. 3a-f) , CLARITY tissue preparation was based on that of Ye et al. 50 without modification. iDISCO+ tissue preparation for tissue antigenicity, autofluorescence measurement and rigidity comparison was performed by following the original iDISCO+ protocol 61 with minor modifications. PFA tissues (see above) postfixed at 4 °C 24 h were washed in PBS with 0.02% sodium azide at room temperature overnight. After cutting into hemispheres, tissues were dehydrated sequentially with 20%, 40%, 60% and 80% MeOH for 1 h each at RT, followed by 100% MeOH twice for 1 h each. Tissues were chilled at 4 °C and bleached with prechilled 5% H 2 O 2 (1:5 dilution of 30% H 2 O 2 with MeOH) at 4 °C overnight. After briefly washing with 100% MeOH twice, tissues were rehydrated sequentially in 80%, 60%, 40% and 20% MeOH for 1 h each at RT, followed by PBS with 0.02% sodium azide for 1 h at RT. At this point, 100-µm slices or 1-mm sagittal blocks were prepared by a vibratome and further processed for each experiment (see "Tissue antigenicity test" and "Tissue rigidity comparison"). For tissue integrity and size comparison measurements, we followed the most recent iDISCO+ protocol from the iDISCO website (https://idiscodotinfo.files.wordpress.com/2015/04/whole-mount-staining-bench-protocolmethanol-dec-2016.pdf).
Virus injection.
Mice were anesthetized using 3% isoflurane with oxygen (1 L/min). After loss of the toe-pinch reflex, the skull was secured onto a stereotaxic (Kopf ), and 500 nL of RV-mOrange-PSD95-EGFP was injected bilaterally into the dentate gyrus (−3.5 mm, ±2.5 mm, −2.8 mm for the anterior-posterior (AP), medio-lateral (ML) and dorso-ventral (DV) axes from bregma). At 6 d after injection, the mice were killed and PFA-processed.
Autofluorescence analysis. C57BL/6 mice were perfused and then prepared according to the standard protocols of each tissue-processing method described above. Fixed samples were then sliced into 100-µm sections using a vibratome. Tissues postfixed with glutaraldehyde at 37 °C were prepared using the postfixation protocol described above. Tissues were cleared in either the 200 mM SDS buffer (pH 9.5, 37 °C, 3 d; GA, CLARITY, SHIELD), 8% SDS buffer (pH 7.4, 37 °C, 3 d; PACT), or 67% dichloromethane, 33% methanol (3 h, RT for 100-µm slices; iDISCO+). After SDS-based buffer clearing, tissues were extensively washed with PBST overnight before imaging. Uncleared PFA tissues and cleared GA (both fixed at 4 °C and 37 °C), PACT, CLARITY, SHIELD and iDISCO+ tissues were immersed in optical clearing media (PACT: RIMS 60 , iDISCO+: dibenzyl ether (DBE), others: Protos-based immersion medium with 50 g of diatrizoic acid) for imaging. The samples were imaged with four commonly used excitation wavelengths-405, 488, 561 and 630 nm-with emission detection ranges of ~60 nm (+5 nm to ~+65 nm from the excitation wavelength) to measure background autofluorescence. Images were acquired from similar regions of brain with similar coordinates and at least three independently perfused and processed mice brains were used for the experiments. 100-µm slices of RV mOrange-expressing tissue (see "Virus injection")were fixed with GA or SHIELD according to the slice fixation protocol and subjected to confocal microscope imaging (see Supplementary  Table 3 for imaging conditions).
Protein loss quantification. Coronal brain blocks 1 mm thick (PFA control, GA-processed or SHIELD-processed) were incubated in 1 mL of SDS clearing solution (200 mM SDS, pH 9.0) for 12 h at 70 °C. The protein content of the supernatant was quantified using a Bio-Rad DC protein assay kit, following the instructions in the manufacturer's manual.
Tissue antigenicity test. GA, PACT, CLARITY and SHIELD-processed mice brain sections with 100 µm thickness (see "Preparation of PFA, GA, PACT and iDISCO+ tissues") were cleared at 37 °C for 3 h with either 8% SDS buffer at pH 7.4 (PACT) or 200 mM SDS buffer at pH 9.5 (GA, CLARITY and SHIELD). Cleared sections were thoroughly washed with PBS with 1% Triton-X 100 by multiple buffer exchanges, followed by overnight incubation at RT, and then used for immunostaining. Uncleared PFA and cleared GA, PACT, CLARITY and SHIELD-processed mouse brain sections were incubated in PBST with 2% normal donkey serum (NDS) at RT for 1 h for blocking, followed by incubation with primary antibodies [rabbit anti-FoxP2 (ab16046, Abcam, MA), rabbit anti-calretinin (ab702, Abcam, MA), rabbit anti-parvalbumin (PV27, SWANT, Switzerland), rabbit anti-NeuN (2430S, Cell Signaling Technology), mouse anti-GFAP (3670S, Cell Signaling Technology), rabbit anti-iba1 (019-19741, Wako Chemicals, Japan), rat anti-MBP (ab7349, Abcam, MA), mouse anti-NF-H (2836S, Cell Signaling Technology)] with a 1:300 dilution factor (1 µL in 300 µL of PBST with 2% NDS) at RT overnight. For iDISCO+ slices, the original protocol 61 was employed with permeabilization, blocking and primary staining buffers as described in the paper, with a 1:300 dilution factor for primary antibody incubation (see "Preparation of PFA, GA, PACT and iDISCO+ tissues"). After washing with PBST with 2% NDS or iDISCO+ washing buffers for at least 8 h, the sections were incubated in PBST with 2% NDS with corresponding secondary antibodies (anti-rabbit, 111-607-008; anti-mouse IgG1, 115-607-185; anti-rat, 112-607-008; Jackson Immunoresearch; 1 µL in 300 µL of PBST with 2% NDS, or iDISCO+ secondary staining buffer) overnight at RT. Washing was performed in PBST with 2% NDS or iDISCO+ washing buffers at RT for at least 8 h, followed by PBST washing for 1 h. The sections were then imaged in PBST using a confocal microscope. For delipidation, the iDISCO+ sections were dehydrated in 20%, 40%, 60%, 80% and 100% MeOH for 5 min each, briefly cleared in 67% dichloromethane, 33% MeOH for 15 min, briefly washed in 100% dichloromethane, and then rehydrated in 67% dichloromethane, 33% MeOH, 100%, 80%, 60%, 40%, 20% MeOH, PBS and PBST for 5 min each. All images were acquired at the very surface of tissue sections, where the background signal induced by light scattering disappeared. Similar brain regions with similar coronal coordinates were chosen to allow pair-wise comparisons among different tissues (PFA control, GA, PACT, CLARITY, SHIELD and iDISCO+ processed). To quantify the SNRs of antibody staining, three sections from each group were prepared, stained and imaged as described above. Regions of interest for signal and background measurements were manually segmented, and their mean intensities were analyzed using ImageJ software.
For the antibody compatibility test in Supplementary Figure 2a,e,g,h , uncleared PFA control, GA or SHIELD-fixed mouse brain sections at 200 µm thickness were incubated in PBST with primary antibodies (1 µg in 200 µL of PBST) at RT overnight. When the concentration of antibody was unknown, 1 µL of antibody was used. After washing with PBST for several hours, sections were incubated in PBST with corresponding secondary antibodies (2 µg in 200 µL of PBST) at RT overnight. Sections were then imaged in PBST using a confocal microscope after washing in PBST at RT for at least 8 h. To avoid light scattering caused by tissue opacity, all images were acquired at the very surface of tissue sections, within the top 10 µm. Similar brain regions within similar coronal coordinates were chosen to allow pair-wise comparisons among different tissues (PFA control, GA, SHIELD-processed). To quantify the SNRs of antibody staining, four sections from each group were prepared, stained and imaged as described above. Image analysis was performed as described in the paragraph above.
Multiround immunostaining. SHIELD-processed coronal slices obtained from H-line mice at 100 µm thickness were stained with primary antibodies (5 µg per antibody) preincubated with dye-conjugated Fc-specific Fab fragments (3:1 molar ratio between the Fab fragment and the primary antibody, Jackson Immunoresearch) for 12 h at 4 °C in PBST. Following imaging, the slices were incubated in the destaining buffer (7 mM SDS, 0.5 M Tris-HCl, 1% (w/v) 2-mercaptoethanol, pH 6.8) for 18 h at 37 °C to remove bound antibodies. Subsequent rounds of immunostaining were performed similarly.
Fluorescence in situ hybridization (FISH)-hybridization chain reaction (HCR).
To demonstrate the versatile applicability of SHIELD tissue for various FISH experiments, a series of oligonucleotide probes with different lengths of antisense probe sequences were employed. DNA oligonucleotides with 18-to 22-nt, 35-nt and 50-nt antisense sequences carrying B1, B3 and B5 initiator sequences flanking the 5′ or 3′ ends for 18-to 22-nt and 35-nt probes and flanking both ends for 50-nt probes were synthesized by IDT (Coralville, IA) and used without further purification. Dye-conjugated hairpin probe sets (B1-Alexa Fluor 647, B3-Alexa Fluor 488 and B5-Alexa Fluor 546) were purchased from Molecular Instruments (Pasadena, CA) or prepared in-house using the standard NHS-ester coupling reaction scheme (B1-Cy5) 62 .
Probe sequences for somatostatin (B5-SST), neuropeptide Y (B1-NPY), YFP (B1-YFP) and GAD1 (B1-GAD1, 22 nt) were obtained as previously described 12, [62] [63] [64] . For 35-nt probes, we tiled 35-nt Gad1 and Fos probes along the coding regions of the target genes and selected probe sequences to be 45-60% GC and melting temperatures to be <80 °C. vGluT1 and vGluT2 35nt probes were designed by OligoArray under the guidance of the previous publication 65 . The 3′ end of the 35-nt probe sequences was appended to a 4-nt ATAT linker followed by the B1I2, B3I2 or B5I2 HCR initiator sequences.
Using 100-or 200-µm SHIELD tissues cleared at 37 °C for 12 h using 200 mM SDS buffer at pH 9.5, initial transcript-targeting probe hybridization was performed overnight (37 °C, 15-16 h) in hybridization buffer (30% (v/v) formamide for 18-to 22-nt probes, 30-40% (v/v) formamide for 35-nt probes, and 50% (v/v) formamide for 50-nt probes, in 2× SSC with 10% (w/v) dextran sulfate with an average MW of 500 kDa (Sigma D8906) and 1 mg/mL salmon sperm DNA (Sigma D7656, using 10 mg/mL stock, 10 min boiling for denaturation and 10 min snap-cooling in ice before use) at probe concentrations of 1 nM for 18-to 22-nt probes and 2 nM for 35-and 50-nt probes. Once hybridization was finished, stringent washing was performed using three rounds of formamide wash (30% (v/v) formamide for 18-to 22-nt probes or 50% (v/v) formamide for 35-and 50-nt probes in 2× SSCT (0.1% (v/v) Triton X-100), for 1 h each wash at RT for 18-to 22-nt and 35-nt probes and at 37 °C for 50-nt probes), followed by two rounds of 2× SSCT washing at RT for 1 h each. Tissue slices were then placed in amplification buffer (2× SSC, 10% (w/v) dextran sulfate) and equilibrated for 30 min before the addition of appropriate hairpin sets. Before incubation, hairpins were heated to 95 °C for 90 s, then snap-cooled on ice for 30 min. HCR amplification was performed overnight at RT using hairpin concentrations of 120-240 nM in the amplification buffer. After HCR was finished, the samples were washed with three rounds of 2× SSCT, 1 h each at RT, and subjected to confocal imaging.
For (dT) 50 -Cy3 oligonucleotide FISH performed to compare the retention of mRNA among PFA, EDC-CLARITY, GA and SHIELD-processed tissues, 100-µm-thickness tissues cleared at 37 °C for 1 d were hybridized as described before 12 and imaged with a confocal microscope. For the whole-organ-level transcript preservation test, a mouse hemisphere was processed by SHIELD epoxidation with a perfusion protocol, followed by stochastic electrotransport clearing at 37 °C for 8 d. The cleared hemisphere brain was washed in PBST for 1 d at 37 °C with multiple solution changes. Afterwards, a 1 mm slice was obtained by cutting at the central coordinate using a vibratome and hybridized for 2 d at 37 °C as described before 12 , then washed in 2× SSCT, 15% (v/v) formamide at RT for 1 d and 2× SSCT for 3 h at RT. The sample was immersed in Protos-based immersion medium until optically cleared and imaged using a 25×, 0.95 NA water objective. The uniformity of mRNA preservation across the tissue area was determined by oligo-dT staining targeting against poly(A) tails of mRNA molecules.
Structural integrity and tissue size comparison. 1-mm-thick tissue blocks from four different coronal coordinates were cut from hemispheres that had been fixed and/or embedded for PACT, CLARITY, iDISCO+ or SHIELD processing. The surfaces of 1-mm-thick blocks were imaged for autofluorescence signal to record their initial tissue structures. Afterwards the tissue blocks were cleared according to corresponding clearing conditions of each technique 50, 60 . For SHIELD tissue blocks, 37 °C 300 mM SDS buffer was used.
In case of iDISCO+ blocks, the most updated iDISCO+ protocol from the iDISCO website (https://idiscodotinfo.files.wordpress.com/2015/04/wholemount-staining-bench-protocol-methanol-dec-2016.pdf) was used for clearing. To mimic hemisphere tissue clearing condition, 1-mm-thick tissues were delipidated for three times the duration necessary to render the blocks evenly translucent. The delipidated samples were optically cleared and mounted in a manner that prevents any physical compression of the tissue, and autofluorescence and YFP signals of the tissue blocks were imaged. Changes in structural integrity were assessed by calculating the change in ratio between medio-lateral and dorso-ventral lengths of the individual tissue blocks. Changes in the means of medio-lateral and dorso-ventral lengths were used to calculate the size change of the individual tissue blocks. Hemispheres in Supplementary Video 2 were cleared with the same condition as for the 1-mm-thick tissue, while the PACT hemisphere was cleared for 6 d and the SHIELD hemisphere was cleared with a SmartClear II Pro (Life Canvas Technologies, MA) at 42 °C for 5 d.
Tissue rigidity comparison. Brain hemispheres of C57BL/6 mice were prepared with the standard protocol for each tissue processing method by perfusion (see "Autofluorescence analysis"). Sagittal sections at the most medial coordinate with 1 mm thickness were acquired by cutting on a vibratome. Tissues were cleared using either 200 mM SDS buffer (pH 9.5, 45 °C: PFA, 1 d; CLARITY, 3 d; SHIELD 2.5 d), 8% SDS buffer (pH 7.4, 45 °C, 1d; PACT), or 67% dichloromethane/33% methanol (3 h, RT; iDISCO+). After SDS clearing, tissues were washed with 1X PBST (0.1% v/v Triton X-100) for 1 d. iDISCO+ tissues were washed with 100% DCM for 20 minutes twice, then incubated in DBE. Tissues were balanced on a lab brush to measure the relative curvature caused by gravity. The curvature was extracted from a tissue photo by interpolating the centerline of the tissue using graphical user interface-based Matlab code, img2curve.m from mathworks.com. At least three independently prepared sections were employed to obtain the mean curvature value for each tissue processing method.
Rapid SPIM imaging and automatic atlas alignment. SHIELD brain hemispheres were imaged using an axially swept 66, 67 light-sheet microscope (SmartSPIM, Lifecanvas Technologies, MA) equipped with a 2.6×, NA 0.2 detection objective (uniform axial resolution ~4 µm). Postprocessed images were downsampled to 25 × 25 × 25 µm voxel size and automatically aligned to annotated autofluorescence atlas from Allen Brain Institute (version 3) 68 by linear and nonlinear image transformation processes. SHIELD processing of human tissues. Human brain tissues were obtained from the Massachusetts General Hospital brain bank. The 2-mm-thick coronal slabs were incubated in the supernatant of 10% (w/v) P3PE solution in PBS for 2 d at RT, then were incubated in the supernatant of 10% (w/v) P3PE solution in 0.1 M sodium carbonate buffer at pH 10 at 37 °C for 3 h. Following fixation, human tissues were cleared passively via incubation in the same SDS-based clearing solution (200 mM SDS, pH 9.5) at 80 °C until transparent. Optical clearing of human tissues was done with Protos-based immersion medium. Figure 4c , tissues were stained using lectin 594 and syto16 nuclear dye at 37 °C. For antigenicity testing for Figure 4 , 100-µm slices were generated from a piece of human brain tissue with a vibratome and SHIELD-processed as described above. The tissues were cleared at 37 °C for 1 d and thoroughly washed in PBST for 1 d. Antigen retrieval and antiautofluorescence treatments were performed by incubation in 10 mM sodium citrate buffer at pH 6 with 0.05% (v/v) Tween 20 for 3 h at 80 °C for antigen retrieval, followed by incubation in 50 mM ammonium acetate and 100 mM copper sulfate solution overnight at RT for reduction of autofluorescence 69 . After thorough washing in PBST, tissues were incubated with rabbit anti-parvalbumin (ab11427, Abcam, MA), rabbit anti-calretinin (ab702, Abcam, MA), rat anti-MBP (ab7349, Abcam, MA), mouse anti-NFL (846002, BioLegend), chicken anti-GFAP (GFAP, Aves), rabbit anti-NPY (30914, Abcam, MA), rabbit anti-Iba1 (019-19741, Wako Chemicals, Japan), rabbit anti-MMP-13 (39012, Abcam, MA), mouse anti-SMI312 (24574, Abcam, MA), rabbit anti-calbindin (ab11426, Abcam, MA), chicken anti-TH (TYH, Aves) or mouse anti-TPH2 (PA1-778, Invitrogen) in PBST overnight at RT using 1:300 dilution factors for all but NFL (1:150). After the primary antibody incubation, tissues were washed in PBST for 3 h at RT, and incubated in dye-conjugated secondary antibodies (Abcam, MA) for 3 h at RT using 1:300 dilution factors. Tissues were then washed in PBST for 3 h at RT and mounted in Protos-based immersion medium. Once the tissues were optically cleared, the samples were imaged with Leica confocal microscope using 10× 0.3 NA, 20× 0.5 NA or 25× 0.95 NA water immersion objectives.
Human tissue staining. For
For 1-mm-thick human brain tissue used for volumetric immunostaining, a piece of human cortical section (typically 1 cm × 1 cm × 1 mm) was incubated in the supernatant of 10% (w/v) P3PE solution in PBS for 1.5 d at 4 °C. The tissue was thermally equilibrated to RT for ~15 min, followed by incubation in the supernatant of 1% (w/v) P3PE solution in 0.1 M sodium carbonate buffer at pH 10 at 37 °C for 1 d. Following fixation, tissues were washed three times with PBS for 1 h at RT, and then were passively cleared in the SDS clearing solution (200 mM SDS, pH 9.5) at 80 °C overnight. Cleared tissues were extensively washed with PBST and the solution was exchanged four or five times during the course of the day, followed by overnight incubation. Antigen retrieval was performed as previously described, but no copper sulfate treatment was conducted. For antibody staining, a piece of 1-mm-thick tissue was cut to a size of 2 mm × 3 mm × 1 mm. The tissue was subjected to primary antibody staining using mouse anti-GFAP (3670S, Cell Signaling Technology) and rabbit anti-calretinin (ab702, Abcam, MA) in PBST at RT for 2 d using a 1:50 dilution factor (10 µL antibody solution in 500 µL PBST). Then the tissue was washed with PBST for 1 d with frequent solution exchanges, followed by overnight incubation. Secondary antibody staining was performed with Fab fragment dye conjugates with RRX (anti-Rb, 111-297-008, Jackson ImmunoResearch) and Alexa 647 (anti-mouse IgG1, 115-607-185, Jackson ImmunoResearch) from Jackson ImmunoResearch in PBST at RT for 2 d using a 1:50 dilution factor. After PBST washing for 1 d, the tissue was immersed in Protos-based immersion medium until optically cleared and imaged by a Leica confocal microscope with a 25×, 1.0 NA CLARITY objective immersed in RI-matching oil (RI = 1.458). A z-step size of 3 µm was used to image the tissue volume of, 443.29 µm × 443.29 µm × 1,017 µm.
Biopsy sample processing. Fresh mouse brains were dissected and placed in ice-cold PBS before core needle biopsy samples were prepared by piercing using an 18G blunt needle with a sharpened tip. Biopsies were incubated for 45 min in PFA (4% (w/v) in PBS) or in SHIELD perfusion solution, followed by 0.1 M sodium carbonate buffer at pH 10 for 30 min. All solutions were prewarmed and maintained at 37 °C during incubation. For tumor biopsy sampling, mouse kidney tissue harboring breast cancer metastasis was used. Human breast cancer cell line MDAMB231 was inoculated into immunodeficient NSG mice via left ventricle injection. Five weeks after injection, animals were perfused with ice-cold PBS, followed by 4% ice-cold PFA. Organs harboring metastasis were collected and put into long-term storage in 4% PFA in PBS at RT. SHIELD processing was performed in the same manner described above except that PFA was not included in the SHIELD perfusion solution because the kidney had been cured (>1 month) in 4% PFA in PBS at RT. 1-mm-square pole biopsies were prepared from a mouse kidney using a vibratome and a surgical knife.
Rapid clearing and staining of biopsy samples. Rapid clearing of fixed biopsy tissues was achieved with a modified SmartClear II Pro (Life Canvas Technologies) with an external 300 W electrophoresis PowerPac HC power supply from Bio-Rad to apply higher voltage (250V). To maintain the temperature below 70 °C, all insulation material in the SmartClear II Pro was removed and the device was operated in a cold room at 4 °C. Operational parameters for the SmartClear device were 4-6 V/mm for electric field strength, 0.1 r.p.m. for electric field rotation frequency and 70 °C for clearing temperature. 3% (w/v) SDS buffer titrated to 9.5 pH was used as the clearing buffer. The cleared biopsy tissues were stained using a custom device as described by Kim et al. 28 . Operational parameters were 8-10 V/mm for electric field strength, 0.1 r.p.m. for electric field rotation frequency and 30 °C for staining temperature. 20 mM Tris buffer titrated to pH 7.5 with 20% (w/v) d-sorbitol and 1% (w/v) BSA was used as the staining buffer. The samples were stained for 1 h with 5 µL of 10× concentrated lectin-594 (DL-1177, Vector Laboratories, CA) and 15 µL of rabbit anti-histone-H3 antibody (12230S, Cell Signaling Technology, MA) in 4 mL of staining buffer. 20 µL of anti-Ki-67 antibody (11882S, Cell Signaling Technology, MA) was used for labeling mouse kidney biopsy tissue. SHIELD-MAP tissue processing protocol. SHIELD-processed mouse brain tissues were cleared with 300 mM SDS clearing buffer (pH 9.0) for 10 d at 37 °C (for a 1-mm-thick block) or at 45 °C (for a 3-mm-thick block or hemisphere) while shaking, then washed overnight at RT with PBS containing 1% (v/v) Triton-X100 and then with PBS. If necessary, cleared tissue was cut with a vibratome (VT1000S, Leica Biosystems, Germany). The tissue was then incubated in 4 Monomer solution incubation was done for >8 h for 200-µm-thick sections, >1 d for 1mm-thick blocks, or >2 d for 3-mm-thick or larger tissues. We purchased multiple bottles of sodium acrylate, made 38% (w/v) solutions in DI water, and checked their colors. The sodium acrylate bottle exhibiting the least yellow color in the 38% (w/v) solution was used to make the monomer solution. The monomer solution was centrifuged at 7,200g for 15 min at 4 °C and only the supernatant was used. Alternatively, the monomer solution was made without adding VA-044 and then was placed at 4 °C for more than 3 d, and the supernatant was used after adding VA-044. After the monomer solution incubation, the tissue was placed between slide glasses sealed with BluTack (Bostik, Australia) to be immersed in the monomer solution. MAP gel embedding was performed under nitrogen gas purge (10 p.s.i.) at 33 °C for 4 h. Care was taken not to trap any air bubbles inside the tissue and surrounding monomer solution. After gelation, gel formed outside of the tissue was carefully removed and the tissue was rehydrated in PBS for several hours before it was placed into DI water for tissue expansion. The expansion ratio was quantified by comparing tissue thickness before and after expansion.
SHIELD-MAP validation: fluorescence retention.
To quantify tissue fluorescence preservation by SHIELD during MAP processing, without being affected by mouse-to-mouse and cell-to-cell fluorescent transgene variability, Thy-1 H+YFP mice littermates were perfused with PFA or SHIELD perfusion solution (N = 3 mice for PFA and N = 4 mice for SHIELD) and the brains were processed according to their respective protocols (see "PFA, CLARITY, GA-SWITCH, PACT and iDISCO+ processing" and "SHIELD whole organ processing protocol"). After postfixation and washing in PBS with 0.02% sodium azide, 200µm-thick sections were made with a vibratome and their surfaces were imaged to assess the initial YFP fluorescence of selected set of cells in cerebral cortices from two different brain coordinates. Both PFA and SHIELD tissues were subjected to the same delipidation condition (37 °C 5 d, 300 mM SDS solution) and then MAP-processed for expansion. Afterwards, the same set of previously imaged cells was imaged again. Total fluorescence inside the set of cells before and after MAP processing was used to calculate fluorescence retention.
SHIELD-MAP validation: distortion analysis on SHIELD-MAP tissue.
To quantify tissue distortion by SHIELD-MAP processing, we used the previously established experimental protocol and algorithm 28 . 200-µm-thick SHIELD mouse brain tissue expressing EGFP was imaged after incubation in Protosbased immersion medium. Special care was taken to mount the sample without any stretching or compression. After unmounting and washing in PBS, the imaged tissue was MAP-processed and then expanded in DI water. The same region of the tissue was imaged again with the same microscope and objective lenses. Neuronal structures expressing EGFP were used as 3D geometrical markers to perform distortion analysis.
Semiautomated spine segmentation was performed on images acquired from the expanded SHIELD-MAP tissue with a 40×, 1.25 NA lens (79 nm × 79 nm pixel size for the expanded sample corresponding to a 26 nm × 26 nm pixel size for the pre-expansion sample) or a 20×, 1.0 NA lens (63 nm × 63 nm pixel size postexpansion corresponding to 21 nm × 21 nm pixel size pre-expansion) using Imaris software (Bitplane).
Integrated circuit mapping. PV-Cre mice (Jackson ImmunoResearch Laboratories, stock number 008069) and AAV-FLEX-mRuby2-Synaptophysin-EGFP injection were used to target PV + neurons in the right hemisphere globus pallidus externa (GPe; −0.15 mm, +2.1 mm and +3.4 mm in the AP, ML and DV axes). Three weeks after virus injection, brains were SHIELDprocessed. After the SHIELD-ON step, the brains were washed in PBST and then sectioned to make a 1-mm-thick sagittal block harboring most of the GPe, subthalamic nucleus (STN) and substantia nigra reticulata (SNr) (1.04 mm-2.04 mm in the ML axis from the bregma).
After clearing, the tissue block was stained with FISH probes targeting Gad1 as described above in the FISH experimental section. Hybridization was conducted for 2 d at 37 °C followed by stringent washing with 2× SSCT, 50% (v/v) formamide for 1 h at RT three times each, 2× SSCT, 30% (v/v) formamide overnight at RT, and 2× SSCT at RT for 1 h three times each. HCR was performed for 2 d using the B1-Cy5 hairpin at 240 nM, and washing was performed for 1 d using 2× SSCT. All samples were imaged after incubation in Protos-based immersion medium at RT. The part of the tissue block including GPe, STN, nRT, GPi and SNr was imaged using a confocal microscope. Gad1 FISH HCR signal was destained by DNase I treatment (4716728001, Roche, Switzerland; 20:2,000 in PBS at RT for 12 h). The sample was then stained with rabbit anti-calretinin antibody (ab702, Abcam, MA) for several days and imaged using the confocal microscope. The tissue was further MAP-processed for super-resolution imaging. After the threefold linear expansion in DI water, a light-sheet microscope (SmartSPIM, Lifecanvas Technologies, MA) with a 10×, 0.6 NA objective were used to image the expanded sample.
A total of three 3D datasets were generated from the same sample. Confocal imaging of the tissue after Gad1 mRNA FISH resulted in a 7.3-GB Imaris file. Subsequent confocal imaging in the tissue after calretinin immunostaining generated a 6-GB Imaris file. Light-sheet microscope imaging of the SHIELD-MAP expanded tissue resulted in 2.1 TB of tiff files, which were 2× downsampled and then were stitched to produce a 158-GB Imaris file. The latter Imaris file was used to reconstruct axon arborization of a single GPe-PV + neuron with its putative axosomatic connections in multiple brain areas. Processing of the 3D images was done on a PC with Intel i7 3.4-GHz processor, 128 GB RAM and a graphics card with 4 GB memory.
Axon tracing was conducted via rigorous review of the volumetric data using Imaris software (Bitplane). A PV-mRuby + neuron was chosen and its axon was traced semiautomatically with the help of Imaris software's filament tracer (using its 'autodepth' or 'manual' mode). Tracing accuracy was continuously assessed by examining the data from multiple angles of view and multiple optical planes. In the event of any ambiguity, raw image volumes were used to confirm the accuracy of axonal tracing. For especially dense areas that needed even further confirmation (for example, axon ramification near target neuronal soma), the tissue area in question was imaged via a confocal microscope with a 25×, 0.95 NA objective lens after full tissue expansion. The entire trace of the neuron was confirmed by at least two individuals. The confocal microscope and the 25×, 0.95 NA objective were used to image areas with putative axosomatic connectivity. The pre-expansion voxel size was 30 nm in the x and y axes and 0.333 µm in the z axis.
The confocal image volumes for regions of interest were used to resolve axon ramification and Syp-EGFP + presynaptic boutons in the putative axosomatic connections of downstream neurons.
To count Gad1 + Syp-EGFP + neurons in the SNr of this sample, multiple optical sections with a fixed interval (100 µm) were unbiasedly selected from the image volume and then all neurons in the SNr area were counted. mRuby2 + neurons were counted from the entire volume of GPe.
Attenuation coefficient. Light attenuation by PFA and P3PE-processed samples were quantified with a method based on a previous publication 70 . Briefly, 100-µm-thick PFA-and P3PE-processed tissue sections were imaged with a transmitted fluorescence light microscope (EVOS FL, ThermoFisher). The intensity of transmitted light through the samples was measured by calculating the mean intensity of the part of the image containing cerebral cortical layers 2-5 to calculate the attenuation coefficient based on the Beer-Lambert law:
where I is the intensity of the light transmitted through the sample, I 0 is the light reached the detector without sample on its light path, µ is attenuation coefficient and L is the thickness of the sample.
Refractive index measurement. PFA-fixed human brain tissue stored in PBS with 0.02% sodium azide was cut in two, and one half was P3PE-fixed by incubating in the supernatant of 10% (w/v) P3PE in PBS at 4 °C for 24 h and then in pH 10, 0.1 M carbonate buffer at 37 °C for 24 h. After washing in PBS with 0.02% sodium azide, the PFA-fixed half and further P3PE-fixed half were completely dried and their refractive indices at 437.2 nm, 487.7 nm and 589.3 nm were measured with a refractometer (Abbermat WR-MW, Anton Paar, Austria).
Statistics and reproducibility.
All statistical tests were performed in Graphpad Prism 6. n values, type of replicate and results of the statistical tests are indicated in main text or figure legends. Here is the information on the reproducibility of representative results shown in figures and supplementary figures. In Figure 1 , data in j,k,m were repeated two more times with similar results, and data in l were repeated one time with a similar result. In Figure 2 , experiments in a-c, i and m were repeated 3 times independently to make the graphs in d, j and n, respectively. Data in f and g were confirmed in 2 independent experiments with similar results. The experiment for k and l was done once. Data in o and p-q were reproduced in 2 and 3 independent experiments, respectively, with similar results. In Figure 3 , data in a,b and in e were confirmed in 4 and 3 independent experiments, respectively, to produce the bar graphs in c,d and f, respectively. Results in g were confirmed in 7 independent experiments with similar results. In Figure 4 , results in d-f were confirmed at least in 2 independent experiments with similar results. Experiments in g-i were repeated 3 times with similar results. Experiments in a-c were done once. In Figure 5 , experiments in b-d, f, j and m,n were repeated in 3, 10, 2 and 2 independent trials with similar results. Experiments in e,j were done twice in total with similar results. Experiments in o were done once. The results in h were repeated in 4 different independent experiments to make graph in i. In Figure 6 , experiments in b,c,e were repeated independently 4 times with similar result. Experiments in g-i were repeated in 10 other cells with similar results. In Supplementary Figure 1 , experiments in b-e were repeated independently 2 times with similar results. In Supplementary  Figure 2 , experiments in e were done at least in 2 independent experimental trials and provided similar results. The experiment in d was done once. The results in f and g were obtained in 3 and 4 independent experiments, respectively, to generate bar graphs in Figure 2j and Supplementary Figure 2h , respectively. In Supplementary Figure 3, experiments in a-c, d , e and f-h were done in 10, 3, 10 and 3 independent trials, respectively, with similar results. Experiments in j were repeated 3 times independently to make the bar graph in i. In Supplementary Figure 4 , data in a,b were confirmed at least in one more of independent experiment with similar results. In Supplementary  Figure 5 , data in c were confirmed in more than 10 independent experiments with similar result. Experiments in d were repeated three times with similar results. The experiment in e was done once.
Code availability. The custom code used in this study is available from the corresponding author upon reasonable request.
